| scholarly article | Q13442814 |
| P2093 | author name string | Ying Chen | |
| Jie Chen | |||
| Chao Li | |||
| Xiaowei Lu | |||
| Dong Weng | |||
| Fangwei Liu | |||
| Wujing Dai | |||
| P2860 | cites work | Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. | Q53200046 |
| Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. | Q53256514 | ||
| Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. | Q53957276 | ||
| The carotenoid lutein enhances matrix metalloproteinase-9 production and phagocytosis through intracellular ROS generation and ERK1/2, p38 MAPK, and RARβ activation in murine macrophages. | Q54448181 | ||
| Type 2 immune response associated with silicosis is not instrumental in the development of the disease | Q56834653 | ||
| Experimental silicosis: a shift to a preferential IFN-gamma-based Th1 response in thoracic lymph nodes | Q73843372 | ||
| CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model | Q79765352 | ||
| CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo | Q80142486 | ||
| What are regulatory B cells? | Q82249253 | ||
| Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model | Q83374824 | ||
| CD19(+)CD1d(+)CD5(+) B cell frequencies are increased in patients with tuberculosis and suppress Th17 responses | Q83504166 | ||
| Identifying Regulatory B Cells (B10 Cells) that Produce IL-10 in Mice | Q85185765 | ||
| Notes from the field: update: silicosis mortality - United States, 1999-2013 | Q24824097 | ||
| IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis | Q28476584 | ||
| Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells | Q28732193 | ||
| CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice | Q33745170 | ||
| Regulatory B cells play a key role in immune system balance | Q34033040 | ||
| CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients | Q34093165 | ||
| Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. | Q34144779 | ||
| Tregs promote the differentiation of Th17 cells in silica-induced lung fibrosis in mice | Q34277943 | ||
| Th17 can regulate silica-induced lung inflammation through an IL-1β-dependent mechanism | Q34336840 | ||
| Induction of IL-10-producing CD1dhighCD5+ regulatory B cells following Babesia microti-infection | Q34447223 | ||
| Presence of Foxp3-expressing CD19(+)CD5(+) B Cells in Human Peripheral Blood Mononuclear Cells: Human CD19(+)CD5(+)Foxp3(+) Regulatory B Cell (Breg). | Q34521067 | ||
| Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells | Q34987934 | ||
| Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production | Q35016309 | ||
| Regulatory B cells and allergic diseases | Q35062229 | ||
| Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice | Q35187089 | ||
| Potent effects of dioscin against liver fibrosis | Q35317884 | ||
| Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. | Q35484992 | ||
| Repeated exposure to Aspergillus fumigatus conidia results in CD4+ T cell-dependent and -independent pulmonary arterial remodeling in a mixed Th1/Th2/Th17 microenvironment that requires interleukin-4 (IL-4) and IL-10. | Q35665448 | ||
| Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. | Q36385029 | ||
| In Vitro Induction of Allergen-Specific Interleukin-10-Producing Regulatory B Cell Responses by Interferon-γ in Non-Immunoglobulin E-Mediated Milk Allergy | Q36485721 | ||
| Deficiency of regulatory B cells increases allergic airway inflammation | Q36497879 | ||
| Regulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice | Q36553694 | ||
| Regulatory role of B cells in a murine model of allergic airway disease. | Q36957781 | ||
| Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis | Q37031308 | ||
| The 'short' history of regulatory B cells | Q37090662 | ||
| Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation | Q37176336 | ||
| Regulatory B and T cells in infections | Q37232197 | ||
| Regulatory B cells as inhibitors of immune responses and inflammation | Q37256986 | ||
| IL-12 can alleviate Th17-mediated allergic lung inflammation through induction of pulmonary IL-10 expression | Q37276907 | ||
| Reduction of IL-17A might suppress the Th1 response and promote the Th2 response by boosting the function of Treg cells during silica-induced inflammatory response in vitro. | Q37622871 | ||
| B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer | Q37690373 | ||
| Effector and regulatory B cells: modulators of CD4+ T cell immunity | Q37708012 | ||
| Regulatory B cells in autoimmune diseases | Q37729359 | ||
| A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis | Q37818921 | ||
| IL-10 producing regulatory B cells in mice and humans: state of the art. | Q37980170 | ||
| CD4+ T lymphocytes in lung fibrosis: diverse subsets, diverse functions | Q38060461 | ||
| IL-10 controls Th2-type cytokine production and eosinophil infiltration in a mouse model of allergic airway inflammation | Q39604276 | ||
| A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand | Q42568871 | ||
| Regulatory B cells that produce IL-10: a breath of fresh air in allergic airway disease. | Q42764563 | ||
| A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. | Q42767100 | ||
| IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis | Q43084852 | ||
| Neutralization of interleukin-17A delays progression of silica-induced lung inflammation and fibrosis in C57BL/6 mice. | Q44779559 | ||
| Activation of CD4⁺ Foxp3⁺ regulatory T cells proceeds normally in the absence of B cells during EAE. | Q47844479 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 28911 | |
| P577 | publication date | 2016-06-29 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Role of IL-10-producing regulatory B cells in modulating T-helper cell immune responses during silica-induced lung inflammation and fibrosis | |
| P478 | volume | 6 |
| Q47113769 | Association between nonspecific interstitial pneumonia and presence of CD20+ B lymphocytes within pulmonary lymphoid follicles. |
| Q38756261 | B lymphocytes in renal interstitial fibrosis |
| Q92135995 | B-1 Cells May Drive Macrophages Susceptibility to Trypanosoma cruzi Infection |
| Q47135902 | Dioscin Exerts Protective Effects Against Crystalline Silica-induced Pulmonary Fibrosis in Mice |
| Q59795167 | Emerging Role of Immunosuppression in Diseases Induced by Micro- and Nano-Particles: Time to Revisit the Exclusive Inflammatory Scenario |
| Q33837257 | Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages |
| Q90307119 | Human monocytic myeloid-derived suppressor cells impair B-cell phenotype and function in vitro |
| Q41430983 | IL-10-Producing B Cells Suppress Effector T Cells Activation and Promote Regulatory T Cells in Crystalline Silica-Induced Inflammatory Response In Vitro. |
| Q37637477 | IL-10-Producing CD1dhiCD5+ Regulatory B Cells May Play a Critical Role in Modulating Immune Homeostasis in Silicosis Patients |
| Q39314792 | Immune monitoring as prerequisite for transplantation tolerance trials |
| Q57147435 | Involvement of Hookworm Co-Infection in the Pathogenesis and Progression of Podoconiosis: Possible Immunological Mechanism |
| Q52727564 | Killer (FASL regulatory) B cells are present during latent TB and are induced by BCG stimulation in participants with and without latent tuberculosis. |
| Q47772304 | Loss of regulatory characteristics in CD4+ CD25+/hi T cells induced by impaired transforming growth factor beta secretion in pneumoconiosis |
| Q90131716 | Lung Transplantation Has a Strong Impact on the Distribution and Phenotype of Monocyte Subsets |
| Q91620789 | N-acetylcysteine tiherapeutically protects against pulmonary fibrosis in a mouse model of silicosis |
| Q97067630 | Polarization of Immune Cells in the Pathologic Response to Inhaled Particulates |
| Q55241957 | Type 2 Immune Mechanisms in Carbon Nanotube-Induced Lung Fibrosis. |
| Q41221440 | miR-155 Regulates IL-10-Producing CD24hiCD27+ B Cells and Impairs Their Function in Patients with Crohn's Disease |
Search more.